Vanguard Portfolio Management
LXRX icon

Vanguard Portfolio Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Vanguard Portfolio Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.66M Buy
2,357,749
+1,811,149
+331% +$3.53M ﹤0.01% 2403
2026
Q1 		$853K Buy
+546,600
New +$795K ﹤0.01% 2849

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management's LXRX Position: Q2 2026 in Review

Vanguard Portfolio Management increased its Lexicon Pharmaceuticals (LXRX) stake by 331% in Q2 2026, buying an estimated $3.53M and bringing the position to 2,357,749 shares worth $5.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2403.

Vanguard Portfolio Management first reported a position in LXRX in Q1 2026 and has held it in 2 quarters since. 149 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

  • Vanguard Portfolio Management held 2,357,749 shares of Lexicon Pharmaceuticals worth $5.66M as of Q2 2026.
  • Vanguard Portfolio Management bought 1,811,149 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $3.53M.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #2403 holding.
  • Vanguard Portfolio Management first reported a position in Lexicon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 149 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.